v3.25.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Assets    
Cash and cash equivalents $ 78,542 $ 59,968
Restricted cash 152,431 154,657
Loans receivable at fair value 2,770,486 2,778,523
Capitalized software and other intangibles, net 81,884 86,588
Right of use assets - operating 9,324 9,775
Other assets 133,638 137,592
Total assets 3,226,305 3,227,103
Liabilities    
Secured financing 445,495 535,469
Asset-backed notes at fair value 863,859 1,080,690
Asset-backed borrowings at amortized cost 1,281,274 984,333
Corporate financing 199,669 203,751
Lease liabilities 16,124 18,200
Other liabilities 53,785 50,851
Total liabilities 2,860,206 2,873,294
Stockholders' equity    
Common stock, $0.0001 par value - 1,000,000,000 shares authorized at March 31, 2025 and December 31, 2024; 37,773,188 shares issued and 37,501,165 shares outstanding at March 31, 2025; 36,383,879 shares issued and 36,111,856 shares outstanding at December 31, 2024 7 7
Common stock, additional paid-in capital 615,165 612,642
Accumulated deficit (242,764) (252,531)
Treasury stock at cost, 272,023 shares at March 31, 2025 and December 31, 2024 (6,309) (6,309)
Total stockholders’ equity 366,099 353,809
Total liabilities and stockholders' equity $ 3,226,305 $ 3,227,103

Source

HTML PDF
XBRL
ZIP